CCL22 and nasopharyngeal carcinoma: Analysis from Tumor Cancer Genome Atlas combined with published NPC RNA-Seq expression data indicated that the epithelial malignancies NPC and GC both had increased levels of CCL17, CCL22, and the Treg marker FOXP3 (219).